News & Analysis on Clinical Trial Services & Contract Research And Development
HistoWiz: $32m investment in lab automation and AI
By Jenni Spinner
- Last updated on
Digital histopathology service provider HistoWiz has announced the closing of a $32m USD Series A financing round. The investment reportedly will enable the firm to focus on implementing automation and artificial intelligence solutions to share quality slides online.
“Our mission is to help researchers find cures by accelerating histopathology and enabling global collaboration,” said Ke Cheng, founder and CEO of HistoWiz. “The Series A financing will allow HistoWiz to expand our services, build a Flagship lab with the latest tissue-sectioning and embedding robots, grow our team to better serve clients, and continue to innovate in this field.”